Under the slogan Turning The Impossible into Possible, we are Artist Bio, established in August 2024 in Korea, based on Targeted Protein Degradation (TPD) technology. Our key technologies include Autophagosome-tethering compounds (ATTEC) and Proteolysis Targeting Chimera (PROTAC). With the mindset of The Real Thing!!, we are committed to developing genuine new drugs, securing competitiveness through verified data and technology. We proudly present ourselves as a young, energetic biotech venture. For any inquiries about our company, feel free to contact us at atistbio@gmail.com. |